Pallas Health vs Strut Health: Which GLP-1 Approach Fits You
Quick comparison and verdict: Pallas Health vs Strut Health
Pallas Health and Strut Health both offer telehealth GLP-1 programs but take different clinical and product approaches. Early verdict: choose Pallas Health if you want a clinician to pick between FDA-approved injectable brands and US-compounded injectables, and choose Strut Health if you specifically want specialized oral semaglutide options.
Start a Pallas Health intake for injectable or compounded options
How they differ: formats and medication focus
Pallas Health offers both FDA-approved injectable GLP-1s such as Wegovy, Ozempic, Zepbound, and Mounjaro and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand is not the right fit. Strut Health specializes in oral semaglutide lozenges and emphasizes oral-based program options. This is the clearest functional difference: Pallas supports brand-name injectables plus compounded injectables; Strut centers on oral semaglutide.
Pricing and plan structure compared
Pallas lists compounded semaglutide at $139 first month, then $597 every 12 weeks for a $199 monthly average, and compounded tirzepatide at $179 first month, then $897 every 12 weeks for a $299 monthly average. Pallas also lists cash-pay brand pricing for Wegovy, Zepbound, Ozempic and Mounjaro with monthly cash-pay figures on its site. Strut Health promotes oral GLP-1 options with pricing from $199 per month and captured landing-page claims mentioning $99 in some landing-page elements. Both providers state no insurance billing; Pallas explicitly says cash-pay only. Preserve regulatory note: compounded medications are not FDA-approved.
Explore Strut Health oral semaglutide options
Care model and clinician involvement
Pallas Health is 100% online with clinician review of your health history to personalize plans, and in most states intake is asynchronous with a video visit required in seven states plus Washington, D.C. Provider care, check-ins and messaging are included in Pallas plan prices with no membership fee. Strut Health offers guided consultations and ongoing progress communication with a clinical focus on oral medication management. Strut emphasizes a streamlined consult process for oral therapies. Both involve a clinician determining medical necessity or eligibility.
Safety, compounding, and regulatory notes
Both providers offer compounded semaglutide options and the supplied evidence includes the regulatory statement that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Pallas explicitly states that compounded medications are prepared by US-licensed compounding pharmacies and that Pallas does not manufacture or compound medication. Strut captured content notes compounded semaglutide is prepared by a U.S.-licensed compounding pharmacy pursuant to an individualized prescription and reiterates that compounded medications are not FDA-approved.
Top differences at a glance
| Criteria | Pallas Health | Strut Health |
|---|---|---|
| Medication formats | Brand-name injectables and US-compounded injectables | Oral semaglutide specialization |
| Starting price (compounded) | $139 first month; $199/mo avg for semaglutide | From $199 per month; landing page also shows $99 in some elements |
| Care model | 100% online; clinician review; check-ins and messaging included | Guided consults with ongoing progress communication |
| Compounding note | Compounded in the USA; not FDA-approved | Compounded by US-licensed pharmacies; not FDA-approved |
| Best for | Patients wanting clinician choice of brand injectable or per-patient compounded injectable | Users specifically seeking oral semaglutide plans |
Other practical differences
Pallas markets an all-in plan price that includes provider care, check-ins and messaging with no membership fee and notes free expedited discreet shipping. Pallas also states plans renew every 12 weeks for compounded options, so cancellation timing matters. Strut focuses on a no-frills telehealth path for oral therapies and notes that compounded semaglutide is prescribed based on medical necessity, available only to patients who fail or cannot use commercially available GLP-1 medications as determined by a licensed physician.
Sign up for Pallas Health clinician review
Start Strut Health guided consults for oral therapy
Conclusion and who should choose which
When weighing Pallas Health vs Strut Health, the main tradeoffs are product format and program focus. Choose Pallas Health if you want a clinician to evaluate and pick between FDA-approved injectable brands and US-compounded injectables with an all-in plan price that includes provider care. Choose Strut Health if you are specifically seeking specialized oral semaglutide lozenges and a streamlined oral-focused telehealth pathway. Both offer clinician oversight and both note that compounded medications are not FDA-approved.
Start a Pallas Health intake for injectable or compounded options